ADial Pharmaceuticals is a privately held biopharmaceutical company focused on the discovery and development of products for the treatment of addictions and addictive disorders. ADial’s lead product, AD04, is in late stage development for the treatment of alcoholism in patients of targeted genotypes, which make up about 35 percent of the population.
U.Va. Founders: Dr. Bankole A. Johnson, Ming D. Li